Hans Ageland

Hans Ageland

Fundador en REDWOOD PHARMA AB .

63 años
Health Technology
Consumer Services
Commercial Services

Perfil

Hans Ageland founded Esperion Therapeutics, Inc. in 1998, where he worked as Vice President-Production and Redwood Pharma AB in 2012, where he is working as Chief Operating Officer from 2012.
Mr. Ageland also founded Unitech Pharma AB, Artery Therapeutics, Inc., Trobio AB, and Bioage AB, where he worked as Chief Executive Officer.
Mr. Ageland also currently works at Ateljé Grön AB, as Deputy Director and Daniel & Sebastian Byggentreprenad AB, as Deputy Director.
Mr. Ageland also formerly worked at Medivir AB, as Vice President-Production and Pharmacia AB, as Project Manager.
Mr. Ageland received his graduate degree from Royal Institute of Technology.

Cargos activos de Hans Ageland

EmpresasCargoInicio
REDWOOD PHARMA AB Fundador 20/01/2012
Bioage AB Director Ejecutivo -
Ateljé Grön AB Corporate Officer/Principal -
Corporate Officer/Principal -
Todos los cargos activos de Hans Ageland

Antiguos cargos conocidos de Hans Ageland.

EmpresasCargoFin
Pharmacia AB Corporate Officer/Principal -
ESPERION THERAPEUTICS, INC. Fundador -
MEDIVIR AB Corporate Officer/Principal -
Trobio AB Fundador -
Fundador -
Ver el detalle de la experiencia de Hans Ageland.

Formación de Hans Ageland.

Royal Institute of Technology Graduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Hans Ageland.

Relaciones

12

Relaciones de 1er grado

11

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas3
ESPERION THERAPEUTICS, INC.

Health Technology

MEDIVIR AB

Health Technology

REDWOOD PHARMA AB

Health Technology

Empresas privadas7
Pharmacia AB

Health Technology

Health Technology

Commercial Services

Bioage AB

Trobio AB

Ateljé Grön AB

Industrial Services

Ver las conexiones de la empresa
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA